Joe Kiani, CEO of Masimo, criticized Apple's blood oxygen feature in the Apple Watch during an interview on Bloomberg TV's @technology at 9:30amPT with Ed Ludlow, claiming it is unreliable and consumers are better off without it. Kiani, whose company is in a legal battle with Apple over the patent dispute, confirmed that there have been no recent settlement talks, as reported by @mike_wuerthele. Apple has countered the claims, stating the feature is accurate and lifesaving.
Masimo CEO: Apple users are better off without Apple Watch pulse oximetry https://t.co/2ztXwiZVWx #Apple
Masimo CEO says Apple Watch users better off without blood oxygen feature, calls it unreliable https://t.co/9SqPU94RDq by @filipeesposito
Apple says that Kiani’s claims are false and that its watch’s blood oxygen feature is accurate, works very well for customers and in some cases can save lives. https://t.co/5Y64uFKR3x
Masimo CEO Joe Kiani took advantage of an interview to slam Apple's implementation of pulse oximetry in the Apple Watch, and confirm that there not been recent settlement talks. By @mike_wuerthele https://t.co/uYBvnxWlss
Masimo CEO: Apple Watch Blood Oxygen Sensor is Not Reliable, Customers Are 'Better Off Without It' https://t.co/0utIlFXCId https://t.co/xojEqlbDRX
The Masimo CEO, waging a legal fight with Apple over a blood oxygen feature, said that consumers are better off without the iPhone maker’s version of the technology https://t.co/KKO9dYBgYB
NEW: Masimo CEO Joe Kiani says customers are better off without the Apple Watch blood oxygen feature, in an interview on Bloomberg TV with @EdLudlow https://t.co/kqEWbNVrDM
INTERVIEW: Massimo CEO @JoeKiani joins me on @technology today at 9:30amPT on the ongoing Apple blood oxygen patent dispute. What questions do you have for Joe and for @masimo? https://t.co/cJyRBaro6k